BackBluejay Diagnostics Overview

Bluejay Diagnostics Accounts Payable

Track Bluejay Diagnostics's accounts payable ($670K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$674089.00
519.47% YoYΔ $565272.00 vs prior year quarter

Peer trimmed avg / median

Loading

Bluejay Diagnostics Accounts Payable History

Loading

Bluejay Diagnostics vs. peers: Accounts Payable Comparison

Loading

Bluejay Diagnostics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bluejay Diagnostics (BJDX) FAQ

The latest accounts payable for BJDX is $670K as of June 2026. That compares with $110K in the prior-year period — up 519.5% year over year. Investors often review this figure alongside Bluejay Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BJDX's accounts payable moved from $110K to $670K — a 519.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bluejay Diagnostics's operating scale or balance-sheet position.

A accounts payable figure of $670K for BJDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BJDX's accounts payable ($670K), review year-over-year change from $110K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.